{
  "openalex_id": "W2885403585",
  "doi": "https://doi.org/10.1158/1538-7445.am2018-ddt02-04",
  "title": "Abstract DDT02-04: BAY 2402234: A novel, selective dihydroorotate dehydrogenase (DHODH) inhibitor for the treatment of myeloid malignancies",
  "abstract": "Abstract Acute myeloid leukemia (AML), the most common acute leukemia in adults, is an aggressive hematologic malignancy resulting in bone marrow failure with a poor outcome; overall survival is approximately 25% at five years. Treatment options, in particular for the elderly population, are limited. Induction chemotherapy of cytarabine and an anthracycline (7+3) remains unchanged standard of care since its introduction in the early 1970s and there is a high medical need for new therapies (Yates et al. Cancer Chemother Rep 1973). DHODH is a key enzyme in the de novo pyrimidine synthesis converting dihydroorotate to orotate. Using a HOXA9 driven phenotypic screen to overcome differentiation arrest in myeloid cells, we have recently identified DHODH as a surprising novel target to overcome differentiation blockade in AML (Sykes et al. Cell 2016). Differentiation therapy already showed its enormous clinical benefit potential in the small subset of patients diagnosed with acute promyelocytic leukemia (APL) following treatment with all-trans retinoic acid with five-year survival exceeding 85% and should be considered the ultimate therapeutic goal for all AML subsets (Lo-Coco et al. NEJM 2013). Here, we disclose for the first time the structure and functional characterization of the novel DHODH inhibitor BAY 2402234. BAY 2402234 is a selective low-nanomolar inhibitor of human DHODH enzymatic activity. In vitro, it potently inhibits proliferation of AML cell lines in the sub-nanomolar to low-nanomolar range. BAY 2402234 induces differentiation of AML cell lines also in a sub-nanomolar to low-nanomolar range, demonstrating the anticipated mode of action in cellular mechanistic assays. In vivo, BAY 2402234 exhibits strong in vivo anti-tumor efficacy in monotherapy in several subcutaneous and disseminated AML xenografts as well as AML patient-derived xenograft (PDX) models. Target engagement of the novel DHODH inhibitor BAY 2402234 can be observed by increase of tumoral and plasma dihydroorotate levels after treatment with the inhibitor. Consistent with the in vitro data BAY 2402234 induces AML differentiation in vivo as detected by upregulation of differentiation cell surface markers in xenograft and PDX models after treatment with the inhibitor. Furthermore, differentiation-associated transcriptomic changes were evident following a single administration of BAY 2402234 in vivo. The start of clinical investigations of BAY 2402234 is planned for early 2018. Citation Format: Andreas Janzer, Stefan Gradl, Sven Christian, Katja Zimmermann, Claudia Merz, Hanna Meyer, Timo Stellfeld, Judith Guenther, Detlef Stoeckigt, Henrik Seidel, Pascale Lejeune, Michael Bruening, Ashley Eheim, Thomas Mueller, Ralf Lesche, Martin Michels, Andrea Haegebarth, Marcus Bauser, Sherif El Sheikh, Steven Ferrara, David Sykes, David Scadden. BAY 2402234: A novel, selective dihydroorotate dehydrogenase (DHODH) inhibitor for the treatment of myeloid malignancies [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2018; 2018 Apr 14-18; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2018;78(13 Suppl):Abstract nr DDT02-04.",
  "authors": [
    {
      "display_name": "Andreas Janzer",
      "id": "A5084001403",
      "orcid": null,
      "institutions": [],
      "is_corresponding": false,
      "raw_author_name": "Andreas Janzer"
    },
    {
      "display_name": "Stefan Gradl",
      "id": "A5005190013",
      "orcid": null,
      "institutions": [],
      "is_corresponding": false,
      "raw_author_name": "Stefan Gradl"
    },
    {
      "display_name": "Sven Christian",
      "id": "A5056835247",
      "orcid": null,
      "institutions": [],
      "is_corresponding": false,
      "raw_author_name": "Sven Christian"
    },
    {
      "display_name": "Katja Zimmermann",
      "id": "A5022297061",
      "orcid": "https://orcid.org/0000-0002-3356-8757",
      "institutions": [],
      "is_corresponding": false,
      "raw_author_name": "Katja Zimmermann"
    },
    {
      "display_name": "Claudia Merz",
      "id": "A5039060488",
      "orcid": "https://orcid.org/0009-0008-6380-0335",
      "institutions": [],
      "is_corresponding": false,
      "raw_author_name": "Claudia Merz"
    },
    {
      "display_name": "Hanna Meyer",
      "id": "A5071672332",
      "orcid": null,
      "institutions": [],
      "is_corresponding": false,
      "raw_author_name": "Hanna Meyer"
    },
    {
      "display_name": "Timo Stellfeld",
      "id": "A5024276499",
      "orcid": null,
      "institutions": [],
      "is_corresponding": false,
      "raw_author_name": "Timo Stellfeld"
    },
    {
      "display_name": "Judith Guenther",
      "id": "A5108693473",
      "orcid": null,
      "institutions": [],
      "is_corresponding": false,
      "raw_author_name": "Judith Guenther"
    },
    {
      "display_name": "Detlef Stoeckigt",
      "id": "A5112443721",
      "orcid": null,
      "institutions": [],
      "is_corresponding": false,
      "raw_author_name": "Detlef Stoeckigt"
    },
    {
      "display_name": "Henrik Seidel",
      "id": "A5003451608",
      "orcid": "https://orcid.org/0000-0001-7804-5143",
      "institutions": [],
      "is_corresponding": false,
      "raw_author_name": "Henrik Seidel"
    },
    {
      "display_name": "Pascale Lejeune",
      "id": "A5046614767",
      "orcid": "https://orcid.org/0000-0002-0665-5783",
      "institutions": [],
      "is_corresponding": false,
      "raw_author_name": "Pascale Lejeune"
    },
    {
      "display_name": "Michael Bruening",
      "id": "A5089542232",
      "orcid": null,
      "institutions": [],
      "is_corresponding": false,
      "raw_author_name": "Michael Bruening"
    },
    {
      "display_name": "Ashley Eheim",
      "id": "A5061973032",
      "orcid": null,
      "institutions": [],
      "is_corresponding": false,
      "raw_author_name": "Ashley Eheim"
    },
    {
      "display_name": "Thomas D. Mueller",
      "id": "A5010928036",
      "orcid": "https://orcid.org/0000-0003-1862-7357",
      "institutions": [],
      "is_corresponding": false,
      "raw_author_name": "Thomas Mueller"
    },
    {
      "display_name": "Ralf Lesche",
      "id": "A5009242861",
      "orcid": "https://orcid.org/0000-0003-2953-9352",
      "institutions": [],
      "is_corresponding": false,
      "raw_author_name": "Ralf Lesche"
    },
    {
      "display_name": "Martin Michels",
      "id": "A5111704257",
      "orcid": null,
      "institutions": [],
      "is_corresponding": false,
      "raw_author_name": "Martin Michels"
    },
    {
      "display_name": "Andrea Haegebarth",
      "id": "A5020529398",
      "orcid": null,
      "institutions": [],
      "is_corresponding": false,
      "raw_author_name": "Andrea Haegebarth"
    },
    {
      "display_name": "Marcus Bauser",
      "id": "A5074638741",
      "orcid": null,
      "institutions": [],
      "is_corresponding": false,
      "raw_author_name": "Marcus Bauser"
    },
    {
      "display_name": "Sherif El Sheikh",
      "id": "A5007655656",
      "orcid": "https://orcid.org/0000-0002-1881-7399",
      "institutions": [],
      "is_corresponding": false,
      "raw_author_name": "Sherif El Sheikh"
    },
    {
      "display_name": "Steven Ferrara",
      "id": "A5051824746",
      "orcid": null,
      "institutions": [
        {
          "id": "I107606265",
          "display_name": "Broad Institute",
          "country_code": "US",
          "type": "nonprofit"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Steven Ferrara"
    },
    {
      "display_name": "David B. Sykes",
      "id": "A5088797237",
      "orcid": "https://orcid.org/0000-0002-9788-0221",
      "institutions": [
        {
          "id": "I4210087915",
          "display_name": "Massachusetts General Hospital",
          "country_code": "US",
          "type": "healthcare"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "David Sykes"
    },
    {
      "display_name": "David T. Scadden",
      "id": "A5083648953",
      "orcid": "https://orcid.org/0000-0001-9821-7133",
      "institutions": [
        {
          "id": "I4210087915",
          "display_name": "Massachusetts General Hospital",
          "country_code": "US",
          "type": "healthcare"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "David Scadden"
    }
  ],
  "publication_year": 2018,
  "publication_date": "2018-07-01",
  "type": "article",
  "cited_by_count": 2,
  "is_retracted": false,
  "is_paratext": false,
  "language": "en",
  "source": {
    "id": "S168522863",
    "display_name": "Cancer Research",
    "issn_l": "0008-5472",
    "issn": [
      "0008-5472",
      "1538-7445"
    ],
    "type": "journal",
    "host_organization": "https://openalex.org/P4310320273"
  },
  "volume": "78",
  "issue": "13_Supplement",
  "first_page": "DDT02",
  "last_page": "04",
  "open_access": {
    "is_oa": false,
    "oa_status": "closed",
    "oa_url": null,
    "any_repository_has_fulltext": false
  },
  "concepts": [
    {
      "id": "C2779865431",
      "display_name": "Dihydroorotate dehydrogenase",
      "level": 3,
      "score": 0.7410001
    },
    {
      "id": "C2776601000",
      "display_name": "Acute promyelocytic leukemia",
      "level": 4,
      "score": 0.6595011
    },
    {
      "id": "C2778041864",
      "display_name": "Cytarabine",
      "level": 3,
      "score": 0.6462869
    },
    {
      "id": "C502942594",
      "display_name": "Cancer research",
      "level": 1,
      "score": 0.6014052
    },
    {
      "id": "C2778729363",
      "display_name": "Myeloid leukemia",
      "level": 2,
      "score": 0.5648649
    },
    {
      "id": "C2779282312",
      "display_name": "Myeloid",
      "level": 2,
      "score": 0.5513647
    },
    {
      "id": "C2779117419",
      "display_name": "Idarubicin",
      "level": 4,
      "score": 0.4883487
    },
    {
      "id": "C2908647359",
      "display_name": "Population",
      "level": 2,
      "score": 0.4785348
    },
    {
      "id": "C71924100",
      "display_name": "Medicine",
      "level": 0,
      "score": 0.47329038
    },
    {
      "id": "C2778461978",
      "display_name": "Leukemia",
      "level": 2,
      "score": 0.46011642
    },
    {
      "id": "C2779982571",
      "display_name": "Differentiation therapy",
      "level": 5,
      "score": 0.4272616
    },
    {
      "id": "C200159599",
      "display_name": "Pyrimidine metabolism",
      "level": 4,
      "score": 0.42286116
    },
    {
      "id": "C121608353",
      "display_name": "Cancer",
      "level": 2,
      "score": 0.41610253
    },
    {
      "id": "C98274493",
      "display_name": "Pharmacology",
      "level": 1,
      "score": 0.3740493
    },
    {
      "id": "C86803240",
      "display_name": "Biology",
      "level": 0,
      "score": 0.34841496
    },
    {
      "id": "C203014093",
      "display_name": "Immunology",
      "level": 1,
      "score": 0.30327097
    },
    {
      "id": "C2781121885",
      "display_name": "Retinoic acid",
      "level": 3,
      "score": 0.27856565
    },
    {
      "id": "C126322002",
      "display_name": "Internal medicine",
      "level": 1,
      "score": 0.27083093
    },
    {
      "id": "C81885089",
      "display_name": "Cell culture",
      "level": 2,
      "score": 0.25671133
    },
    {
      "id": "C181199279",
      "display_name": "Enzyme",
      "level": 2,
      "score": 0.20180434
    },
    {
      "id": "C55493867",
      "display_name": "Biochemistry",
      "level": 1,
      "score": 0.17019409
    },
    {
      "id": "C54355233",
      "display_name": "Genetics",
      "level": 1,
      "score": 0.07701671
    },
    {
      "id": "C99454951",
      "display_name": "Environmental health",
      "level": 1,
      "score": 0.0
    },
    {
      "id": "C2776476023",
      "display_name": "Purine",
      "level": 3,
      "score": 0.0
    }
  ],
  "topics": [
    {
      "id": "T12827",
      "display_name": "Biochemical and Molecular Research",
      "score": 0.9997
    },
    {
      "id": "T10526",
      "display_name": "HIV/AIDS drug development and treatment",
      "score": 0.9708
    },
    {
      "id": "T10950",
      "display_name": "Acute Lymphoblastic Leukemia research",
      "score": 0.9557
    }
  ],
  "created_date": null,
  "updated_date": null,
  "indexed_in": [],
  "landing_page_url": "https://doi.org/10.1158/1538-7445.am2018-ddt02-04",
  "pdf_url": null,
  "retrieved_date": "2025-07-30T14:42:29.001035",
  "source_database": "OpenAlex"
}